GPX4, FSP1, and GCH1 were highly expressed, while DHODH expression was low in patients with gliomas with a 1p19q non-codeletion compared to those with a 1p19q codeletion (Figure 1G). This evidence concerns the gene AIFM2 and central nervous system cancer.